H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 82 Citations 21,379 409 World Ranking 602 National Ranking 15
Medicine D-index 84 Citations 25,183 654 World Ranking 7973 National Ranking 186

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Disease

Kenji Kabashima mostly deals with Immunology, Immune system, Cell biology, Atopic dermatitis and Inflammation. His Immunology study frequently intersects with other fields, such as Keratinocyte. His Immune system study incorporates themes from Melanoma and Lymph.

The study incorporates disciplines such as Cytotoxic T cell, IL-2 receptor, Chemokine, Receptor and Dermis in addition to Cell biology. His Atopic dermatitis study combines topics from a wide range of disciplines, such as Psoriasis, Internal medicine, Pathogenesis and T helper cell. His Inflammation study combines topics in areas such as Anatomy and Cutaneous immunity.

His most cited work include:

  • Prostaglandin D2 as a mediator of allergic asthma. (672 citations)
  • Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma† (499 citations)
  • Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma† (499 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Immunology, Dermatology, Immune system, Pathology and Atopic dermatitis. His research in Inflammation, Antigen, Psoriasis, Pathogenesis and Immunoglobulin E are components of Immunology. His study on Immune system is mostly dedicated to connecting different topics, such as Cell biology.

His Atopic dermatitis study frequently links to other fields, such as Internal medicine.

He most often published in these fields:

  • Immunology (53.80%)
  • Dermatology (32.08%)
  • Immune system (23.93%)

What were the highlights of his more recent work (between 2019-2021)?

  • Dermatology (32.08%)
  • Atopic dermatitis (21.28%)
  • Immune system (23.93%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Dermatology, Atopic dermatitis, Immune system, Immunology and Inflammation. In his study, Melanoma is strongly linked to Nivolumab, which falls under the umbrella field of Dermatology. His biological study spans a wide range of topics, including Internal medicine, Randomized controlled trial and Clinical endpoint.

His Immune system research is multidisciplinary, incorporating perspectives in Cell type, Intravital Imaging and Pathology. His studies in Thymic stromal lymphopoietin, Immunoglobulin E, Filaggrin, Acquired immune system and Pathogenesis are all subfields of Immunology research. His work carried out in the field of Inflammation brings together such families of science as Dendritic cell, Antibody, Innate lymphoid cell and Cell biology.

Between 2019 and 2021, his most popular works were:

  • Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials (51 citations)
  • Type 2 immunity in the skin and lungs. (41 citations)
  • Type 2 immunity in the skin and lungs. (41 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Disease

His primary scientific interests are in Atopic dermatitis, Immunology, Immune system, Inflammation and Dermatology. His Atopic dermatitis research includes elements of Internal medicine, Quality of life, Clinical trial and Interleukin 15. His study in Incidence extends to Immunology with its themes.

His research ties Cytotoxic T cell and Immune system together. His Inflammation research incorporates themes from Antigen, Antibody, Innate lymphoid cell, In vivo and Histamine. Kenji Kabashima has included themes like Epidermolysis bullosa acquisita, Spirometry, Pemphigoid and Intravenous Immunoglobulins in his Dermatology study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prostaglandin D2 as a mediator of allergic asthma.

Toshiyuki Matsuoka;Masakazu Hirata;Hiroyuki Tanaka;Yoshimasa Takahashi.
Science (2000)

1054 Citations

Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma†

Ryosuke Hino;Kenji Kabashima;Kenji Kabashima;Yu Kato;Hiroaki Yagi.
Cancer (2010)

665 Citations

Possible pathogenic role of Th17 cells for atopic dermatitis.

Chizuko Koga;Kenji Kabashima;Noriko Shiraishi;Miwa Kobayashi.
Journal of Investigative Dermatology (2008)

658 Citations

The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut

Kenji Kabashima;Tomomi Saji;Takahiko Murata;Miyako Nagamachi.
Journal of Clinical Investigation (2002)

505 Citations

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations.

Judith A. Seidel;Atsushi Otsuka;Kenji Kabashima;Kenji Kabashima.
Frontiers in Oncology (2018)

478 Citations

Anti-interleukin-31 receptor a antibody for atopic dermatitis

Thomas Ruzicka;Jon M. Hanifin;Masutaka Furue;Grazyna Pulka.
The New England Journal of Medicine (2017)

403 Citations

Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells.

Kenji Kabashima;Daiji Sakata;Miyako Nagamachi;Yoshiki Miyachi.
Nature Medicine (2003)

350 Citations

Intrinsic Lymphotoxin-β Receptor Requirement for Homeostasis of Lymphoid Tissue Dendritic Cells

Kenji Kabashima;Theresa A. Banks;K. Mark Ansel;Theresa T. Lu.
Immunity (2005)

323 Citations

New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity.

Kenji Kabashima.
Journal of Dermatological Science (2013)

323 Citations

The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.

Shinji Noda;Mayte Suárez-Fariñas;Benjamin Ungar;Benjamin Ungar;Soo Jung Kim.
The Journal of Allergy and Clinical Immunology (2015)

315 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kenji Kabashima

Emma Guttman-Yassky

Emma Guttman-Yassky

Icahn School of Medicine at Mount Sinai

Publications: 163

Shuh Narumiya

Shuh Narumiya

Kyoto University

Publications: 101

Yoshihiro Urade

Yoshihiro Urade

University of Tsukuba

Publications: 69

James G. Krueger

James G. Krueger

Rockefeller University

Publications: 63

Florent Ginhoux

Florent Ginhoux

Agency for Science, Technology and Research

Publications: 61

Makoto Murakami

Makoto Murakami

University of Tokyo

Publications: 56

Ralf Paus

Ralf Paus

University of Miami

Publications: 40

Yukihiko Sugimoto

Yukihiko Sugimoto

Kumamoto University

Publications: 39

Takehiko Yokomizo

Takehiko Yokomizo

Juntendo University

Publications: 39

Jacob P. Thyssen

Jacob P. Thyssen

University of Copenhagen

Publications: 38

Thomas Werfel

Thomas Werfel

Hannover Medical School

Publications: 36

Wolfgang Weninger

Wolfgang Weninger

Medical University of Vienna

Publications: 34

Marcus Maurer

Marcus Maurer

Charité - University Medicine Berlin

Publications: 34

Gil Yosipovitch

Gil Yosipovitch

University of Miami

Publications: 34

Donald Y.M. Leung

Donald Y.M. Leung

National Jewish Health

Publications: 32

Cezmi A. Akdis

Cezmi A. Akdis

University of Zurich

Publications: 29

Something went wrong. Please try again later.